ConductScience.org, home

Gene693232

MIR647: microRNA 647

Cite this record

ConductScience Library. MIR647: microRNA 647. Genes, record 693232. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/693232

FollowSave as evidenceDownload JSON
Sources
13 sources
Release
gene-search-2026-11-13-0.2.1

Gene

Symbol
MIR647
HGNC
Name
microRNA 647
HGNC
NCBI Gene ID
693232
NCBI Gene
HGNC ID
HGNC:32903
HGNC
Ensembl
ENSG00000207554
NCBI Gene
Aliases
MIRN647, hsa-mir-647
NCBI Gene
Type
ncRNA
NCBI Gene

NIH grants35

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleMIR647 papersNewest fiscal year
K12GM081259IRACDA at the University of Pennsylvania: Penn Postdoctoral Opportunities in Research and Teaching (PennPORT).12025
P30CA060553The Robert H. Lurie Comprehensive Cancer Center12025
P30CA138292Winship Cancer Institute Cancer Center Support Grant12025
P30ES009089Center for Environmental Health in Northern Manhattan12025
P30ES010126UNC Center for Environmental Health and Susceptibility12025
UL1TR002366Frontiers Clinical and Translational Science Institute at the University of Kansas12025
P01AG014449Neurobiology of Mild Cognitive Impairment in the Elderly12024
P30ES000002Harvard Chan School NIEHS Center for Environmental Health12024
P30EY031631Center Core Grant for Vision Research12024
P20GM103639Mentoring Translational Cancer Research in Oklahoma22022

Source NIH's project files

See all 35 nih grantsDownload CSV of nih grants

Papers209

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Clinical biochemical significance of STAT6, ERG, and miR-647 expression in prostate cancer: Associations with tumor aggressiveness and patient prognosis.J Med Biochem202642781455PubTator, text miningPubMed
[Retracted] Tumor promoter role of miR‑647 in gastric cancer via repression of TP73.Mol Med Rep202642563686PubTator, text miningPubMed
Insights Into circRNA-Mediated Lipid Metabolism in Cancer Progression.J Cell Mol Med202641652992PubTator, text miningPubMed
Comprehensive transcriptomics and proteomics analysis of neointima formation in human saphenous vein: implications for bypass graft disease.Am J Physiol Heart Circ Physiol202641569144PubTator, text miningPubMed
Circular RNA circAHSA1 serves as a stable serum biomarker for the diagnosis and progression of gastric cancer.Transl Oncol202641330006PubTator, text miningPubMed
Non-coding RNAs PROX1-AS1 and miR-647: Potential Interaction and Prognostic Value in Gastric Cancer.Curr Mol Med202640326038PubTator, text miningPubMed
Resveratrol Sensitizes Temozolomide-Resistant Glioblastoma Cells Through Mitogen-Activated Protein Kinase Pathway Inhibition and P-Glycoprotein Modulation.Drug Res (Stuttg)202541253172PubTator, text miningPubMed
Decoding the functional roles of circular RNAs linked to NF-κB pathway in carcinogenesis.Discov Oncol202540996665PubTator, text miningPubMed
Beyond linear: How circRNAs twist and turn Notch signaling.J Cell Commun Signal202540761890PubTator, text miningPubMed
Diagnostic and Prognostic Potential of Circulating miR-1301-3p, miR-106a-5p, miR-129-5p, miR-3613-3p, and miR-647 microRNAs in Gastric Cancer.Biochemistry (Mosc)202540609990PubTator, text miningPubMed

See all 209 papersDownload CSV of papers

Expression109

This gene's TPM, transcripts per million, in Gene expression: up to six groups of each list, the highest median first.

Median TPM of MIR647

TPM · Band: first to third quartile · Dot: median

Show median tpm of mir647 as

By normal tissue · 6 of 51

Ovary195 samples39.629.6 to 48.7
Brain - Cerebellum533 samples37.526.9 to 48.6
Thyroid687 samples35.127.4 to 43.5
Fallopian Tube9 samples3420.4 to 45.4
Nerve - Tibial636 samples33.626.5 to 41.6
Cervix - Endocervix10 samples32.225.5 to 35.8

By tumor and normal adjacent tissue · 6 of 57

Acute Myeloid Leukemia173 samples20.814.7 to 29.2
Esophageal Carcinoma184 samples10.96.78 to 16.2
Ovarian Serous Cystadenocarcinoma420 samples9.194.67 to 16.2
Rectum Adenocarcinoma167 samples7.134.03 to 13.2
Stomach Adenocarcinoma393 samples7.073.93 to 11.5
Colon Adenocarcinoma502 samples6.212.91 to 10.3

By cell line · 1 of 1

K-562198 samples8.266.65 to 11.7
GroupSamplesSamples that pass QCMedian TPMFirst quartileThird quartileShare with TPM of 1 or more
OvaryNormal tissue19539.629.648.71
Brain - CerebellumNormal tissue53337.526.948.60.994
ThyroidNormal tissue68735.127.443.51
Fallopian TubeNormal tissue93420.445.41
Nerve - TibialNormal tissue63633.626.541.61
Cervix - EndocervixNormal tissue1032.225.535.81
Acute Myeloid LeukemiaTumor17320.814.729.21
Esophageal CarcinomaTumor18410.96.7816.21
Ovarian Serous CystadenocarcinomaTumor4209.194.6716.20.974
Rectum AdenocarcinomaTumor1677.134.0313.20.988
Stomach AdenocarcinomaTumor3937.073.9311.50.967
Colon AdenocarcinomaTumor5026.212.9110.30.92
K-562Cell line1988.266.6511.71

Gene expression release expression-atlas-2026-11-21-0.10.0

Gene expression so far: 43,590 genes, 8,834 studies and 359,840 samples, in release expression-atlas-2026-11-21-0.10.0. Its first release holds GTEx's 19,214 samples, TCGA's 11,348 and 7 SRA projects.

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0.

The results shown here are in whole or part based upon data generated by the TCGA Research Network. TCGA's samples and their metadata come through recount3 from NCI's Genomic Data Commons, https://gdc.cancer.gov, as open data under NIH's Genomic Data Sharing Policy.

recount3, Wilks and colleagues, Genome Biology 2021, https://doi.org/10.1186/s13059-021-02533-6.

The library is for research and education. It is not medical advice. Do not use it to diagnose or treat anyone. Library terms of use

None in this release

  • Proteins
  • Pathways
  • Patents
  • Drugs
  • Trials

Sources 13

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
  • USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
  • USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/693232

GET https://conductscience.org/api/genes/v1/693232/grants?page=2